FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2160667835> ?p ?o ?g. }

• W2160667835 endingPage "663" @default.
• W2160667835 startingPage "647" @default.
• W2160667835 abstract "The selection of therapies for breast cancer is today based on prognostic features (chemotherapy, radiotherapy), hormone receptor status (hormonal therapy) and HER-2 status (trastuzumab therapy). HER-2, p53 and BCL-2 are tumour-related proteins that have the potential to further improve individualisation of patient management, by predicting response to chemotherapy, hormonal therapy and radiotherapy.This paper reviews the rationale for the use of these proteins as predictive factors, as well as the published literature addressing the use of each one to predict response to hormonal therapy, chemotherapy and radiotherapy.HER-2, p53 and BCL-2 remain inadequately assessed as predictive factors in breast cancer. HER-2 evaluation is required for the selection of patients for trastuzumab (Herceptin) therapy, as trials of this therapy have been limited to HER-2 overexpressors. HER-2 overexpression may be predictive of resistance to hormonal therapy. Anthracyclines are effective therapy for breast cancer regardless of HER-2 status, but patients whose tumours overexpress HER-2 appear to receive the greatest relative benefit from this therapy. Studies of HER-2 as a predictor of response to CMF and to radiotherapy are inconclusive at this time. No data yet exist to support the use of p53 or BCL-2 as predictive factors in the therapy of breast cancer.At this point in time, there is inadequate evidence to support the use of HER-2, p53 or BCL-2 to guide the selection of hormonal therapy, chemotherapy or radiotherapy for breast cancer." @default.
• W2160667835 created "2016-06-24" @default.
• W2160667835 creator A5012143202 @default.
• W2160667835 creator A5087380706 @default.
• W2160667835 date "2000-06-01" @default.
• W2160667835 modified "2023-10-16" @default.
• W2160667835 title "The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53 and BCL-2" @default.
• W2160667835 cites W1262485082 @default.
• W2160667835 cites W1562190372 @default.
• W2160667835 cites W1593734817 @default.
• W2160667835 cites W1621124914 @default.
• W2160667835 cites W1644953918 @default.
• W2160667835 cites W1755920412 @default.
• W2160667835 cites W1786761502 @default.
• W2160667835 cites W1856021881 @default.
• W2160667835 cites W1871768557 @default.
• W2160667835 cites W1901376003 @default.
• W2160667835 cites W1922272927 @default.
• W2160667835 cites W1925485320 @default.
• W2160667835 cites W1950270470 @default.
• W2160667835 cites W1976052438 @default.
• W2160667835 cites W1977221327 @default.
• W2160667835 cites W1979319210 @default.
• W2160667835 cites W1980076677 @default.
• W2160667835 cites W1986926262 @default.
• W2160667835 cites W1987783969 @default.
• W2160667835 cites W1988346665 @default.
• W2160667835 cites W1993669933 @default.
• W2160667835 cites W1995675713 @default.
• W2160667835 cites W2000557631 @default.
• W2160667835 cites W2009219057 @default.
• W2160667835 cites W2009489338 @default.
• W2160667835 cites W2022015605 @default.
• W2160667835 cites W2023758607 @default.
• W2160667835 cites W2033742043 @default.
• W2160667835 cites W2036067444 @default.
• W2160667835 cites W2039969104 @default.
• W2160667835 cites W2044247843 @default.
• W2160667835 cites W2052034196 @default.
• W2160667835 cites W2052193554 @default.
• W2160667835 cites W2055961110 @default.
• W2160667835 cites W2059701501 @default.
• W2160667835 cites W2062713892 @default.
• W2160667835 cites W2073760973 @default.
• W2160667835 cites W2075786281 @default.
• W2160667835 cites W2084178781 @default.
• W2160667835 cites W2101577390 @default.
• W2160667835 cites W2115581335 @default.
• W2160667835 cites W2129936913 @default.
• W2160667835 cites W2130866079 @default.
• W2160667835 cites W2159459001 @default.
• W2160667835 cites W2164789874 @default.
• W2160667835 cites W2170143229 @default.
• W2160667835 cites W2222470382 @default.
• W2160667835 cites W2264076879 @default.
• W2160667835 cites W2325286800 @default.
• W2160667835 cites W2328452031 @default.
• W2160667835 doi "https://doi.org/10.1023/a:1008390429428" @default.
• W2160667835 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10942052" @default.
• W2160667835 hasPublicationYear "2000" @default.
• W2160667835 type Work @default.
• W2160667835 sameAs 2160667835 @default.
• W2160667835 citedByCount "165" @default.
• W2160667835 countsByYear W21606678352012 @default.
• W2160667835 countsByYear W21606678352013 @default.
• W2160667835 countsByYear W21606678352014 @default.
• W2160667835 countsByYear W21606678352015 @default.
• W2160667835 countsByYear W21606678352016 @default.
• W2160667835 countsByYear W21606678352017 @default.
• W2160667835 countsByYear W21606678352018 @default.
• W2160667835 countsByYear W21606678352019 @default.
• W2160667835 countsByYear W21606678352020 @default.
• W2160667835 countsByYear W21606678352022 @default.
• W2160667835 countsByYear W21606678352023 @default.
• W2160667835 crossrefType "journal-article" @default.
• W2160667835 hasAuthorship W2160667835A5012143202 @default.
• W2160667835 hasAuthorship W2160667835A5087380706 @default.
• W2160667835 hasBestOaLocation W21606678351 @default.
• W2160667835 hasConcept C121608353 @default.
• W2160667835 hasConcept C126322002 @default.
• W2160667835 hasConcept C143998085 @default.
• W2160667835 hasConcept C2776694085 @default.
• W2160667835 hasConcept C2778311097 @default.
• W2160667835 hasConcept C2779786085 @default.
• W2160667835 hasConcept C2780275930 @default.
• W2160667835 hasConcept C2780521871 @default.
• W2160667835 hasConcept C509974204 @default.
• W2160667835 hasConcept C530470458 @default.
• W2160667835 hasConcept C71924100 @default.
• W2160667835 hasConceptScore W2160667835C121608353 @default.
• W2160667835 hasConceptScore W2160667835C126322002 @default.
• W2160667835 hasConceptScore W2160667835C143998085 @default.
• W2160667835 hasConceptScore W2160667835C2776694085 @default.
• W2160667835 hasConceptScore W2160667835C2778311097 @default.
• W2160667835 hasConceptScore W2160667835C2779786085 @default.
• W2160667835 hasConceptScore W2160667835C2780275930 @default.
• W2160667835 hasConceptScore W2160667835C2780521871 @default.
• W2160667835 hasConceptScore W2160667835C509974204 @default.

• next